<p>Abpro Holdings Inc. is facing potential delisting from the Nasdaq Stock Market due to noncompliance with several Nasdaq Listing Rules following the recent resignations of two board members. The company no longer meets requirements for board and committee independence, including rules mandating a majority of independent directors and minimum independent membership on the audit and compensation committees. While the company’s stock remains listed for now, the Nasdaq Hearings Panel will consider these deficiencies in its ongoing review of Abpro’s continued listing. The company is working to appoint qualified independent directors to restore compliance within the required timeframes. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abpro Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-014903), on February 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</p>

IBBQ

LABD

ABPO

Reuters

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

Proshares Ultra Nasdaq Biotech

Invesco Nasdaq Biotechnology ETF

Abpro

iShares Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

Direxion S&P Biotech Bear 3X

SPDR S&P Biotech

Abpro Holdings, Inc.

Nasdaq Warns Abpro Holdings of Possible Delisting Over Board Compliance Lapses